Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз Ways to improve adherence to long-term injection therapy in multiple sclerosis using the example of pegylated interferon-β1a (sampeginterferon β-1a) Abstract  similar documents
A. N. Boyko
"... Patient adherence to therapy with multiple sclerosis disease-modifying treatments (MS DMTs ..."
 
Vol 15, No 6 (2023) «Gut-brain» axis and multiple sclerosis Abstract  similar documents
M. A. Omarova, A. N. Boyko
"... of diseasemodifying therapies on the gut microbiome in patients with MS. ..."
 
Vol 15 (2023): (Suppl. 1) Prolonged observation after the use of cladribine in multiple sclerosis: efficacy and safety Abstract  similar documents
A. D. Kukushkina, A. N. Boyko
"... neuroinflammatory and neurodegenerative components. The goal of therapy of MS is to reduce the risk of exacerbations ..."
 
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз Art therapy possibilities in the complex treatment of patients with multiple sclerosis Abstract  similar documents
M. E. Guseva, O. V. Matvievskaya, A. N. Boyko
"... Objective: to study the effectiveness of art therapy methods in the complex treatment ..."
 
Vol 10, No 1 (2018) New drugs for anti-B-cell therapy of multiple sclerosis Abstract  similar documents
A. N. Boyko, N. Yu. Lashch, M. E. Guseva
"... The review presents the data characterizing the mechanism of action of anti-B-cell therapy ..."
 
Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз Experience with cladribine tablets for highly active multiple sclerosis in everyday clinical practice Abstract  similar documents
S. V. Petrov, O. V. Boyko, A. N. Boyko
"... Cladribine tablets are a new drug for the immune reconstitution therapy of highly active multiple ..."
 
Vol 16 (2024): (Suppl. 2) Curcumin as an add-on therapy for multiple sclerosis in patients receiving interferon-beta therapy Abstract  similar documents
A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaya, E. V. Lysogorskaia, A. N. Boyko
"... Search for agents for the add-on therapy of multiple sclerosis (MS) that can enhance the effect ..."
 
Vol 11, No 1 (2019) Experience with anti-B-cell therapy in the pathogenetic treatment of multiple sclerosis Abstract  PDF (Eng)  similar documents
O. V. Boyko, S. V. Petrov, N. Yu. Lashch, M. R. Guseva, A. N. Boyko
"... therapy using ocrelizumab, an anti-CD20 monoclonal antibody. The drug is indicated for primary progressive ..."
 
Vol 17, No 3 (2025) Curcumin as add-on therapy in patients with multiple sclerosis showing a suboptimal response to first-line disease-modifying therapies: clinical outcomes and in vitro data Abstract  similar documents
A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaia, E. V. Lysogorskaia, A. N. Boyko
"... In recent decades, pathogenetic therapy of multiple sclerosis (MS) has advanced significantly due ..."
 
Vol 17, No 3 (2025) Switching from ocrelizumab to ofatumumab: key potential reasons based on real-world clinical practice Abstract  similar documents
A. N. Boyko, T. O. Simaniv, T. A. Prokopyeva, S. V. Petrov, M. V. Melnikov
"... In everyday neurological practice, B-cell-depleting therapies are playing an increasingly ..."
 
Vol 13, No 3 (2021) Results of Expert Council meeting on modern principles of treatment optimization in patients with relapsing-remitting multiple sclerosis using anti-CD20 monoclonal antibody Abstract  similar documents
A. N. Boyko, N. V. Khachanova, D. S. Korobko, D. S. Kasatkin, Ya. V. Vlasov, E. P. Evdoshenko, E. V. Popova, K. Z. Bakhtiyarova, S. A. Sivertseva
"... The article presents the results of the discussion of the use of anti-B-cell therapy in multiple ..."
 
Vol 13, No 2 (2021) COVID-19 vaccination guidelines for patients with multiple sclerosis Abstract  similar documents
N. V. Khachanova, N. A. Totolyan, Ya. V. Vlasov, S. A. Sivertseva, M. V. Davydovskaya, E. P. Evdoshenko, A. P. Prodeus, M. N. Zakharova, N. N. Spirin, A. N. Boyko
"... therapies.  ..."
 
Vol 11, No 4 (2019) Recommendations from the Expert Meeting «Secondary progressive multiple sclerosis: unresolved issues and prospects» Abstract  similar documents
N. V. Khachanova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, E. P. Evdoshenko, S. A. Sivertseva, T. E. Schmidt, M. V. Shumilina
 
Vol 15 (2023): (Suppl. 1) Diagnostic criteria and treatment of neuromyelitis optica spectrum disorders (NMOSD) Abstract  similar documents
T. O. Simaniv, K. Z. Bakhtiyarova, A. N. Belova, Z. A. Goncharova, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, T. N. Trushnikova, E. L. Turova, T. I. Khaibullin, M. A. Sherman, A. N. Boyko
 
Vol 12, No 3 (2020) Recommendations for the use of cladribine tablets for the pathogenetic treatment of patients with highly active multiple sclerosis Abstract  similar documents
K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. V. Davydovskaya, M. N. Zakharova, N. A. Malkova, A. I. Nilov, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, F. A. Khabirov, M. V. Shumilina
"... activity signs that are detected by magnetic resonance imaging (MRI) regardless of previous therapy with MS ..."
 
1 - 15 of 15 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)